New Drug Approvals in 2011

Research in Texas

Research in Tennessee

Research in Your Backyard: Developing Cures, Creating Jobs - Pharmaceutical Clinical Trials in Minnesota

Research in Illinois

Biopharmaceutical Research Companies are Developing Nearly 200 Medicines for the Most Common Chronic Health Problem in the United States

How You Can Help Fight a $1.1 Trillion Disease

Washington, D.C. (November 21, 2011) — In honor of Alzheimer's disease month, the Pharmaceutical Research and Manufacturers of America (PhRMA) produced a compelling video series highlighting the impact this devastating disease has on patients, caregivers and the U.S. health care system.

PhRMA Statement on Protecting Intellectual Property

Washington, D.C. (October 26, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement regarding the introduction of the Stop Online Piracy Act:
 
"PhRMA applauds the introduction of the Stop Online Piracy Act and looks forward to working with Chairman Smith and members of the House Judiciary Committee on an issue critical to innovation in the U.S.
 

PhRMA Statement on Intellectual Capital

Washington, D.C. (October 25, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement regarding a new report on the value of intellectual capital in the U.S.:"
 

Medicines in Development for Older Americans - Backgrounder

Alzheimer’s disease– A gene therapy in development for the treatment of Alzheimer's disease is designed to deliver nerve growth factor (NGF) to the brain.  NGF is a naturally occurring protein that is important for neuron survival.  The gene treatment is injected into a region in the brain where neuron degeneration occurs in Alzheimer’s disease.

Pages

Subscribe to RSS - Innovation